Goldfarb Branham LLP is investigating the takeover of Cephalon, Inc. (Nasdaq: CEPH) by Teva Pharmaceutical Industries, Ltd. to ensure that shareholders’ rights are preserved in the buyout for $81.50 per share. Concerned Cephalon shareholders are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com about their rights and remedies.

“This buyout is a 6% premium over the previous day’s closing price,” said securities lawyer Hamilton Lindley. “Analysts have placed the price target at between $92 and $119 per share. Our firm’s potential stockholder lawsuit seeks to ensure that investors’ receive the fair price and information that they are entitled to as Cephalon stockholders.”

Goldfarb Branham LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. Cephalon investors – or anyone with knowledge about this issue – should contact lawyer Hamilton Lindley at hlindley@goldfarbbranham.com or 877-583-2855.

Cephalon (NASDAQ:CEPH)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Cephalon.
Cephalon (NASDAQ:CEPH)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Cephalon.